Cheap arthritis drug tested as safer alternative to steroids for transplant complication
NCT ID NCT04932564
Summary
This study tested whether a drug called leflunomide could safely control joint and muscle problems caused by graft-versus-host disease (GVHD) after a stem cell transplant. The goal was to find an alternative to long-term steroid use, which causes many side effects. The trial was very small and ended early, so results are limited.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GVHD, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer
Navi Mumbai, Maharashtra, 410210, India
Conditions
Explore the condition pages connected to this study.